E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/7/2013 in the Prospect News PIPE Daily.

Resolute Oncology completes $1.44 million private placement of stock

Deal consists of 2.87 million common shares; each share sold at $0.50

By Devika Patel

Knoxville, Tenn., Feb. 7 - Resolute Oncology Inc. raised $1.44 million in a private placement of stock on Feb. 4, according to an 8-K filed Thursday with the Securities and Exchange Commission.

The company sold 2.87 million common shares at $0.50 apiece.

The private Bridgewater, N.J., company offers cancer treatment products.

Issuer:Resolute Oncology Inc.
Issue:Common shares
Amount:$1,435,000
Shares:2.87 million
Price:$0.50
Warrants:No
Settlement date:Feb. 4

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.